1.
Int J Gen Med
; 15: 8677-8684, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36573111
RESUMO
Our aim in this review is to discuss current treatments and investigational products and their effect on patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) and provide suggestions for monitoring disease progression and treatment efficacy.